Literature DB >> 2304056

Primary intraocular lymphoma with lymphomatous meningitis.

P G Hykin1, J E MacSweeney, D Gartry, E Graham.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2304056      PMCID： PMC1292470          DOI： 10.1177/014107689008300122

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

1.  Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma.

Authors:  L N Freeman; A P Schachat; D L Knox; R G Michels; W R Green
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

2.  Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases.

Authors:  E J Rockwood; Z N Zakov; J W Bay
Journal:  J Neurosurg       Date:  1984-08       Impact factor: 5.115

Review 3.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

Review 4.  Intraocular lymphoma: report of three cases and review of the literature.

Authors:  M Trudeau; F A Shepherd; M E Blackstein; M Gospodarowicz; P Fitzpatrick; K P Moffatt
Journal:  Am J Clin Oncol       Date:  1988-04       Impact factor: 2.339

5.  Intracranial disease in non-Hodgkin's lymphoma.

Authors:  G S Venables; S J Proctor; D Bates; N E Cartlidge; D A Shaw
Journal:  Q J Med       Date:  1980

6.  Intraocular involvement of T and B cell lymphomas.

Authors:  E Graham
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

7.  Primary malignant lymphoma of the central nervous system. Results of treatment of 11 cases and review of the literature.

Authors:  K Murray; L Kun; J Cox
Journal:  J Neurosurg       Date:  1986-11       Impact factor: 5.115

Review 8.  Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature.

Authors:  S J Qualman; G Mendelsohn; R B Mann; W R Green
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.